7 February 2019

Richard Bartfai, theme Infectious diseases and global health, and Clemens Kocken (BPRC) received 675,000 euros from ZonMw to uncover the molecular mechanisms underlying dormancy of malaria parasites, a major obstacle to efficient treatment of Plasmodium vivax malaria.

Plasmodium vivax causes severe morbidity in Asia and South-America and is regarded as a major challenge to malaria elimination. The biggest obstacle in fighting P. vivax is the presence of dormant parasites. These, so called, hypnozoites can stay dormant in the liver without any symptoms for weeks to years, survive treatment of blood stage infection and reactivate causing malaria without renewed exposure to infected mosquitos. In order to better target hypnozoites, it is important to unravel the mechanisms behind their dormancy and reactivation. Hypnozoites, however, have long been inaccessible for experimental investigations and hence represent a major knowledge gap in our understanding of the parasite’s life cycle, which in turn hinders drug development.

Therefore, in this project, Clemens Kocken and Richard Bartfai will form a powerful partnership to combine state-of-the-art genomic technologies and a unique transgenic model system to understand mechanisms that drive liver stage parasites into dormancy or dictate their reactivation. These insights may prove essential to further vivax malaria control and elimination by paving the way for new and innovative approaches to target this critical human pathogen.

Related news items

Four Veni grants for young RIMLS researchers

22 July 2019

Four young researchers, affiliated to the RIMLS, have each received a Veni grant of 250,000 Euro from NWO. Our researchers received this prestigious grant for their remarkable and original talent and their ability to carry out innovative research.

read more

Bas Loomans received Mid-Career Award

18 July 2019

Bas Loomans received in Vancouver the STEPHEN BAYNE MID-CAREER AWARD of the International Association for Dental Research (IADR)

read more

4,8 million euros for prevention of tuberculosis among people with diabetes in Africa

16 July 2019

Reinout van Crevel and Lindsey te Brake have received European funding of 4.8 million euros to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.

read more

50.000 grant for Paul de Jonge and Harry Dolstra

15 July 2019

Paul de Jonge and Harry Dolstra, theme Cancer development and immune defense, received a €50.000,- (NWA-IDG) grant for their project regarding cancer immunotherapy.

read more

Handbook of biomarkers and precision medicine a new publication by Alain van Gool

12 July 2019

Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.

read more

The real impact of menstrual complaints on work and school productivity

8 July 2019

Menstrual period symptoms may be linked to nearly nine days of lost productivity every year, through presenteeism, suggests the largest study of its kind, published in the journal BMJ Open. But the real impact on women and society is underestimated and poorly appreciated, say the researchers.

read more